(90 days)
No
The description details a mechanical cleaning system with manual cycle selection via a membrane switch panel. There is no mention of AI, ML, or any data-driven decision-making or learning capabilities.
No
The device is clearly indicated for facilitating the cleaning of dialyzers and is not used for treating any medical condition or disease.
No
This device is used to clean dialyzers, not to diagnose medical conditions or analyze biological samples for diagnostic purposes. It facilitates the reprocessing of medical equipment.
No
The device description clearly outlines a physical, stand-alone countertop system with hardware components like header cleaners, needles, and a membrane switch front panel. It performs a physical cleaning process using water and air.
Based on the provided information, the RenaClear™ Dialyzer Cleaning System is not an IVD (In Vitro Diagnostic) device.
Here's why:
- Intended Use: The intended use is to "facilitate the cleaning of blood and other debris from multiple-use hollow fiber dialyzers prior to being reprocessed". This is a cleaning and preparation step for a medical device (the dialyzer), not a diagnostic test performed on a biological sample to provide information about a patient's health.
- Device Description: The description details a system that uses water and air to clean the dialyzer. It does not involve analyzing biological samples (like blood, urine, etc.) to diagnose, monitor, or screen for diseases or conditions.
- Lack of IVD Characteristics: The document does not mention any of the typical characteristics of an IVD, such as:
- Analyzing biological samples.
- Providing diagnostic information.
- Measuring analytes in a sample.
- Using reagents for testing.
The device is a cleaning system for a medical device (a dialyzer), which falls under a different regulatory category than IVDs.
N/A
Intended Use / Indications for Use
Minntech Corporation's RenaClear™ Dialyzer Cleaning System is used to facilitate the cleaning of blood and other debris from multiple-use hollow fiber dialyzers prior to being reprocessed in an approved dialyzer reprocessing program.
Product codes
78 LIF
Device Description
The RenaClear™ Dialyzer Cleaning System facilitates the cleaning and removal of blood and other debris from multiple-use hollow fiber dialyzers prior to an institutions approved dialyzer reprocessing program. The stand-alone countertop system is equipped with two header cleaners that attach to the blood ports of a dialyzer. The header cleaners have a retractable, rotating, directional needle jet that will inject a water/air mixture into the dialyzer header and blood pathway. Simultaneously the dialyzer dialysate compartment and the exterior of the dialyzer fibers will be pressurized water to achieve reverse ultrafiltration.
The operator, through the use of a membrane switch front panel, controls the RenaClear™ Dialyzer Cleaning System. Operators have the following cycle choices: Dialyzer clean, system clean, system sanatize and system rinse.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Minntech Corporation has performed functional testing to show the 4.1 RenaClear™ Dialyzer Cleaning System is safe and has equivalent performance with respect to the predicate device.
All materials have been tested for material compatability with the chemicals used in the system as specified in the labeling.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 876.5820 Hemodialysis system and accessories.
(a)
Identification. A hemodialysis system and accessories is a device that is used as an artificial kidney system for the treatment of patients with renal failure or toxemic conditions and that consists of an extracorporeal blood system, a conventional dialyzer, a dialysate delivery system, and accessories. Blood from a patient flows through the tubing of the extracorporeal blood system and accessories to the blood compartment of the dialyzer, then returns through further tubing of the extracorporeal blood system to the patient. The dialyzer has two compartments that are separated by a semipermeable membrane. While the blood is in the blood compartment, undesirable substances in the blood pass through the semipermeable membrane into the dialysate in the dialysate compartment. The dialysate delivery system controls and monitors the dialysate circulating through the dialysate compartment of the dialyzer.(1) The extracorporeal blood system and accessories consists of tubing, pumps, pressure monitors, air foam or bubble detectors, and alarms to keep blood moving safely from the blood access device and accessories for hemodialysis (§ 876.5540) to the blood compartment of the dialyzer and back to the patient.
(2) The conventional dialyzer allows a transfer of water and solutes between the blood and the dialysate through the semipermeable membrane. The semipermeable membrane of the conventional dialyzer has a sufficiently low permeability to water that an ultrafiltration controller is not required to prevent excessive loss of water from the patient's blood. This conventional dialyzer does not include hemodialyzers with the disposable inserts (Kiil type) (§ 876.5830) or dialyzers of high permeability (§ 876.5860).
(3) The dialysate delivery system consists of mechanisms that monitor and control the temperature, conductivity, flow rate, and pressure of the dialysate and circulates dialysate through the dialysate compartment of the dialyzer. The dialysate delivery system includes the dialysate concentrate for hemodialysis (liquid or powder) and alarms to indicate abnormal dialysate conditions. This dialysate delivery system does not include the sorbent regenerated dialysate delivery system for hemodialysis (§ 876.5600), the dialysate delivery system of the peritoneal dialysis system and accessories (§ 876.5630), or the controlled dialysate delivery system of the high permeability hemodialysis system § 876.5860).
(4) Remote accessories to the hemodialysis system include the unpowered dialysis chair without a scale, the powered dialysis chair without a scale, the dialyzer holder set, dialysis tie gun and ties, and hemodialysis start/stop tray.
(b)
Classification. (1) Class II (performance standards) for hemodialysis systems and all accessories directly associated with the extracorporeal blood system and the dialysate delivery system.(2) Class I for other accessories of the hemodialysis system remote from the extracorporeal blood system and the dialysate delivery system, such as the unpowered dialysis chair, hemodialysis start/stop tray, dialyzer holder set, and dialysis tie gun and ties. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.
0
RENACLEAR™ DIALYZER CLEANING SYSTEM
510(k) Summary of Safety and Effectiveness
| Manufacturer: | Minntech Corporation |
|---|---|
| Address: | 14605 28th Avenue North |
| Mpls, MN 55447 | |
| USA | |
| Official Contact: | Robert Johnson |
| Vice President, Regulatory Affairs and Quality Assurance |
Minntech Corporation has supplied the following information to the U.S. Food and Drug Administration to support substantial equivalency of the RenaClear™ Dialyzer Cleaning System to other dialyzer pre-cleaning cycles in automated dialyzer reprocessing systems currently in distribution in the United States.
1. Device Description
The RenaClear™ Dialyzer Cleaning System facilitates the cleaning and removal of blood and other debris from multiple-use hollow fiber dialyzers prior to an institutions approved dialyzer reprocessing program. The stand-alone countertop system is equipped with two header cleaners that attach to the blood ports of a dialyzer. The header cleaners have a retractable, rotating, directional needle jet that will inject a water/air mixture into the dialyzer header and blood pathway. Simultaneously the dialyzer dialysate compartment and the exterior of the dialyzer fibers will be pressurized water to achieve reverse ultrafiltration.
The operator, through the use of a membrane switch front panel, controls the RenaClear™ Dialyzer Cleaning System. Operators have the following cycle choices: Dialyzer clean, system clean, system sanatize and system rinse.
-
- Intended Use
Minntech Corporation's RenaClear™ Dialyzer Cleaning System is used to facilitate the cleaning of blood and other debris from multiple-use hollow fiber dialyzers prior to being reprocessed in a dialyzer reprocessing program.
- Intended Use
3. Comparison to Another Device in Commercial Distribution Within the United States
The RenaClear™ Dialyzer Cleaning System is equivalent to other dialyzer precleaning cycles in automated dialyzer reprocessing systems currently in distribution in the United States. The Renatron® II Dialyzer Reprocessing System
1
(K904210) pre-clean cycle is intended to pre-clean multiple-use dialyzers prior to testing and sterilization.
- Summary 4.
- Minntech Corporation has performed functional testing to show the 4.1 RenaClear™ Dialyzer Cleaning System is safe and has equivalent performance with respect to the predicate device.
- 4.2 All materials have been tested for material compatability with the chemicals used in the system as specified in the labeling.
- న. Summary of Substantial Equivalence
Minntech Corporation has provided the above information within the 510(k) to support the claim that the RenaClear™ Dialyzer Cleaning System is safe and effective when used in accordance with the device labeling.
2
Image /page/2/Picture/1 description: The image is a black and white circular logo for the U.S. Department of Health & Human Services. The logo features the department's emblem, which is a stylized image of a human figure embracing a bird. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged around the upper half of the circle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
AUG 30 1999
Mr. Richard M. Ormsbee Regulatory Affairs Associate Minntech Corporation 14605 28th Avenue, N. Minneapolis, MN 55447
Re: K991851 RenaClear™ Dialyzer Cleaning System Dated: May 27, 1999 Received: June 1, 1999 Regulatory Class: II 21 CFR §876,5820/Procode: 78 LIF
Dear Mr. Ormsbee:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act, You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations. Title 21. Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumplions. Failure to comply with the GMP regulation may result in requlatory action. In addition. FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in viro diagnostic devices), piease contact the Office of Compliance at (301) 594-4613, Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
CAPT Daniel G. Schultz, M.D. Acting Director, Division of Reproductive, Abdominal. Ear, Nose and Throat. and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
Indications for Use
510(k) Number (if Known):
Device Name:
RenaClear™ Dialyzer Cleaning System
Indications for Use:
Minntech Corporation's RenaClear™ Dialyzer Cleaning System is used to facilitate the cleaning of blood and other debris from multiple-use hollow fiber dialyzers prior to being reprocessed in an approved dialyzer reprocessing program.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use
(Per21 CFR 801.109)
OR
Over-the Counter-use
(Optional Format 1-1-96)
(Division Sign-Off)
Division of Reproductive, Abdominal, ENT,
and Radiological Devices
510(k) Number K991851